Trichome Financial Corp. Provides Corporate Update

 In News Release
  • Private placement to provide initial capital to deploy into growing pipeline of opportunities
  • New name emphasizes company focus on flexible, alternative capital solutions to the cannabis industry
  • Marc Lustig named Chairman of the Board of Directors

Toronto, Ontario – June 4, 2018 – CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) (“CannaRoyalty”) today announces Trichome Yield Corp., a majority owned subsidiary of CannaRoyalty, has changed its name to Trichome Financial Corp. (“Trichome” or the “Company”), effective June 1, 2018. The new name better reflects the Company’s strategic position as a flexible and responsive provider of capital solutions to the Canadian and international cannabis industry.

“The new name – Trichome Financial Corp. – reflects our emphasis as a value-added specialty finance company focused on the cannabis sector.  With few conventional or alternative capital sources targeting the industry, Trichome believes that there is a large, growing, and underserviced segment of the financing market,” commented Michael Ruscetta, CEO of Trichome. “Along with our founders CannaRoyalty, Stoic Advisory, and Sprott, Trichome is uniquely positioned to provide added-value to our portfolio investments. With our recent investment in 180 Smoke and large pipeline of opportunities, the momentum around Trichome is building rapidly.”

Trichome’s board of directors is composed of professionals with proven investment, M&A and cannabis-industry experience:

  • Michael Ruscetta – CEO of Trichome. Previously managed the RCM Special Situations Fund, served as Co-Head of Goldman Sachs’ Canada Special Situations Group and Managing Director of Amaranth Advisors (Canada).
  • Marc Lustig – Chief Executive Officer of CannaRoyalty. Marc has also been appointed as Chairman of the Board of Directors of Trichome.
  • Afzal Hasan – President and General Counsel of CannaRoyalty.
  • Jonathan Page – Co-founder of Anandia Labs and an Adjunct Professor in the Botany Department at The University of British Columbia.
  • Marissa Lauder –Chief Financial Officer and Corporate Secretary of Street Capital Group Inc. and Street Capital Bank of Canada.
  • Brent Cox – Founding partner of The Inception Companies, a private investment vehicle focused on the global cannabis market. Currently serves on the board of successful vertically integrated U.S. cannabis company The Pharm and is a past board member of MedMen.
  • Tim Diamond – CEO of Whitehall Apartments Corp. Over 20 years of experience in senior and board roles in the financial and lending industries.

Trichome also is pleased to announce that it is commencing a non-brokered private placement for gross proceeds of up to $20,000,000 (the “Private Placement”). The Company intends to use the net proceeds from the Private Placement to deploy into loans to a variety of cannabis sector participants as well as for working capital purposes.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state security laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Trichome

Trichome is a majority-owned subsidiary of CannaRoyalty and was formed to offer credit-based capital solutions to companies operating across the Canadian cannabis value chain. Trichome expects to offer creative credit-based capital solutions to cannabis companies in need of capital for a broad array of requirements. Trichome is focused primarily on addressing the largely underserviced Canadian cannabis market and expects to expand to meet the needs of companies operating in fully legal international markets as those jurisdictions develop.

About CannaRoyalty

CannaRoyalty is an active investor and operator in the legal cannabis industry. Its focus is on building and supporting a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property. CannaRoyalty’s management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt, licensing agreements and its own branded portfolio. CannaRoyalty’s shares trade on the Canadian Stock Exchange (CSE) under the symbol CRZ and internationally on the OTCQX under the symbol CNNRF.

For further inquiries, please contact:

Marc Lustig



Jonathan Ross, CFA

LodeRock Advisors Inc.



For Trichome inquiries, please contact:

Kevin Jarrett, VP, Investments


Forward Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CannaRoyalty’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, statements relating to the Acquisitions, the execution of the Company’s strategy, new opportunities, future growth and other statements.
Although CannaRoyalty has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CannaRoyalty disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CannaRoyalty does not assume any liability for disclosure relating to any other company mentioned herein.